We are live on ! Find out more
MED icon

Medifast

109 hedge funds and large institutions have $86.5M invested in Medifast in 2025 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 25 increasing their positions, 47 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,488% more call options, than puts

Call options by funds: $15.1M | Put options by funds: $953K

10.62% less ownership

Funds ownership: 84.01%73.38% (-11%)

11% less funds holding

Funds holding: 123109 (-14)

31% less capital invested

Capital invested by funds: $126M → $86.5M (-$39.7M)

47% less repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 47

48% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 27

Holders
109
Holders Change
-14
Holders Change %
-11.38%
% of All Funds
1.32%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
14
Increased
25
Reduced
47
Closed
27
Calls
$15.1M
Puts
$953K
Net Calls
+$14.2M
Net Calls Change
-$15.1M

MED Hedge Fund Activity: Q4 2025 in Review

109 of the 8,267 institutional investors tracked by Wall St. Rank reported a position in Medifast (MED) for Q4 2025, worth a combined $86.5M — down 31% from $126M a quarter earlier.

Sellers outnumbered buyers: 27 funds closed out of MED and 14 opened new positions — a net loss of 13 holders — while 47 trimmed existing stakes and 25 added.

The largest buyer was Steamboat Capital Partners, opening a new position worth an estimated $3.31M. The largest seller was Bank of America, cutting an estimated $4.25M.

  • 109 institutional investors held Medifast (MED) as of Q4 2025, down from 123 in Q3 2025.
  • Funds reported $86.5M of Medifast stock for Q4 2025, down 31% quarter-over-quarter.
  • 14 funds opened new Medifast positions in Q4 2025 and 27 closed out, a net change of -13 holders.
  • The largest Medifast buyer in Q4 2025 was Steamboat Capital Partners, an estimated $3.31M added.
  • The largest Medifast seller in Q4 2025 was Bank of America, an estimated $4.25M sold.

Based on aggregated 13F filings for Q4 2025.